Health policy in 2017: Innovation, value and access

January 4, 2017 by Dan Leonard and Chain Drug Review biopharmaceutical research, Dan Leonard, evidence-based medical decision making, medication nonadherence, National Pharmaceutical Council, NPC, pharmaceutical spending, value-based health care Opinion

For the past two years, organizations in the private and public sectors have been working to develop tools to support value-based health care and evidence-based medical decision making. In 2017, these efforts will take on an even greater urgency, driven by the ongoing, accelerating progress of biopharmaceutical research and development. As more — and more